Home Tags Fast Track designation
Tag: Fast Track designation
Test trial results are expected by 2023.
The drug, also known as empagliflozin, was developed by Boehringer Ingelheim and Eli Lilly and Co.
"The fast track designation recognizes that desmoid tumors have a substantial impact on the lives of patients," said Saqib Islam, CEO of SpringWorks Therapeutics.